Depreciation of Silence Therapeutics plc from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Silence Therapeutics plc annual and quarterly Depreciation in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
  • Silence Therapeutics plc Depreciation for the quarter ending 31 Mar 2025 was $73,000, a 17% decline year-over-year.
  • Silence Therapeutics plc annual Depreciation for 2025 was $312,000, a 7.1% decline from 2024.
  • Silence Therapeutics plc annual Depreciation for 2024 was $336,000, a 8.9% decline from 2023.
  • Silence Therapeutics plc annual Depreciation for 2023 was $369,000, a 2.6% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Silence Therapeutics plc Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $312,000 -$24,000 -7.1% 01 Jan 2025 31 Dec 2025 10-K 05 Mar 2026 2025 FY
2024 $336,000 -$33,000 -8.9% 01 Jan 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY
2023 $369,000 -$10,000 -2.6% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $379,000 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY

Silence Therapeutics plc Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $73,000 -$15,000 -17% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $88,000 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.